Сравнение

Glepaglutide vs. Sincalide

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

нет данных

25126-32-3

Молекулярная масса

нет данных

1143.29 g/mol

Период полувыведения

нет данных

Последовательность

нет данных

Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2

Механизм действия

Glepaglutide

As a GLP-2 receptor agonist, glepaglutide has a trophic effect on the intestinal mucosa, enlarging the absorptive surface and thereby improving intestinal uptake of nutrients and fluid.

Sincalide

Sincalide activates CCK receptors, triggering gallbladder contraction and pancreatic enzyme secretion. This effect is used diagnostically to measure the gallbladder ejection fraction (e.g. in HIDA scintigraphy).

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследование на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Glepaglutide	Sincalide
Германия	Не одобрено	Неясно
США	Не одобрено	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Glepaglutide and Sincalide?: Glepaglutide is classified as "Исследования (прочее)", while Sincalide is classified as "Исследования (прочее)". Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Glepaglutide or Sincalide?: The highest available evidence level is "РКИ на людях" for Glepaglutide and "Исследование на людях" for Sincalide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Glepaglutide and Sincalide in Germany and the United States?: Германия: Glepaglutide — Не одобрено, Sincalide — Неясно. США: Glepaglutide — Не одобрено, Sincalide — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Glepaglutide

Sincalide

Германия

Не одобрено

Неясно

США

Не одобрено

Рецептурный

Frequently asked questions

What is the difference between Glepaglutide and Sincalide?

Glepaglutide is classified as "Исследования (прочее)", while Sincalide is classified as "Исследования (прочее)". Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Glepaglutide or Sincalide?

The highest available evidence level is "РКИ на людях" for Glepaglutide and "Исследование на людях" for Sincalide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Glepaglutide and Sincalide in Germany and the United States?

Германия: Glepaglutide — Не одобрено, Sincalide — Неясно. США: Glepaglutide — Не одобрено, Sincalide — Рецептурный. These are factual summaries with source and review date on the individual pages.